ArticleThe journal of pathology. Clinical research2020

Identifying fibroblast growth factor receptor genetic alterations using RNA-based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment.

Songbai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.